Website Update in Progress

Our website is currently being updated. Investor Relations information and the full Press Releases archive remain available below.

Under construction Live soon

Investor Relations

Press Releases

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet

June 25, 2026

Press Releases

Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes

June 17, 2026

Press Releases

Oramed and Lifeward Announce Strategic Transaction

January 13, 2026

Press Releases

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments

January 7, 2026

Press Releases

Oramed Reports Fiscal Third Quarter 2025 Financial Results

November 17, 2025

Press Releases

SEC Filings

Copyright © 2025 Oramed. | Terms & Conditions | Privacy Statement | Cookie Policy